Mediterranean spotted fever in pregnancy

Area of Science:

• Infectious Diseases
• Obstetrics and Gynecology
• Rickettsial Infections

Background:

• Mediterranean spotted fever (MSF) is a tick-borne illness caused by Rickettsia conorii.
• MSF during pregnancy is exceptionally uncommon, posing diagnostic and therapeutic challenges.
• Limited data exist on the safety and efficacy of antimicrobial treatments for MSF in pregnant individuals.

Observation:

• A young pregnant woman presented with symptoms consistent with Mediterranean spotted fever.
• The patient's clinical presentation and diagnostic workup confirmed the diagnosis of MSF.
• The pregnancy was ongoing at the time of diagnosis and initial management.

Findings:

• The patient received a combination therapy of erythromycin and rifampicin.
• The MSF infection showed a favorable response to the prescribed antimicrobial regimen.
• No adverse effects of the treatment on the mother or fetus were reported during the course of management.

Implications:

• This case underscores the importance of considering MSF in pregnant women presenting with febrile illnesses, especially in endemic areas.
• Combination therapy with erythromycin and rifampicin appears to be a safe and effective treatment for MSF during pregnancy.
• Further research is warranted to establish definitive treatment guidelines for rickettsial infections in pregnant populations.